Heparin News and Research

RSS
Heparin, a highly-sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machines. Pharmaceutical grade heparin is derived from mucosal tissues of slaughtered meat animals such as porcine (pig) intestine or bovine (cow) lung.
New approach to cadmium induced hepatoxicity

New approach to cadmium induced hepatoxicity

How asthma and allergy symptoms are triggered

How asthma and allergy symptoms are triggered

Contaminated syringes make 40 people sick

Contaminated syringes make 40 people sick

Safe and effective therapy discovered for patients with protein-losing enteropathy

Safe and effective therapy discovered for patients with protein-losing enteropathy

Anticoagulant bivalirudin following angioplasty in heart attack patients reduces adverse events and bleeding

Anticoagulant bivalirudin following angioplasty in heart attack patients reduces adverse events and bleeding

Landmark stent trial to be presented at TCT 2007

Landmark stent trial to be presented at TCT 2007

New synthetic version of the drug heparin

New synthetic version of the drug heparin

Phase 3 study on novel oral direct thrombin inhibitor

Phase 3 study on novel oral direct thrombin inhibitor

New minimally-invasive coated vascular stent graft in use at Methodist DeBakey Heart Center

New minimally-invasive coated vascular stent graft in use at Methodist DeBakey Heart Center

Studies assess blood clot prevalence outside hospital prevention in hospital

Studies assess blood clot prevalence outside hospital prevention in hospital

Study questions risks of aprotinin during heart surgery

Study questions risks of aprotinin during heart surgery

Proper use of aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke

Proper use of aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

Improving outcomes for patients with acute coronary syndrome

Improving outcomes for patients with acute coronary syndrome

Efforts to standardize heart care are working

Efforts to standardize heart care are working

Sticking with guidelines for acute coronary syndromes benefits even very elderly patients

Sticking with guidelines for acute coronary syndromes benefits even very elderly patients

Micell Technologies presents data on novel drug-eluting stents

Micell Technologies presents data on novel drug-eluting stents

Scientists isolate enzyme that could be used to predict survival for nasopharyngeal cancer

Scientists isolate enzyme that could be used to predict survival for nasopharyngeal cancer

Advances in clinical cardiology

Advances in clinical cardiology

U.S. consumers' health care concerns

U.S. consumers' health care concerns